Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

33.57
Delayed Data
As of Sep 02
 +0.90 / +2.75%
Today’s Change
19.31
Today|||52-Week Range
36.20
+23.28%
Year-to-Date
No recent news for Emergent BioSolutions Inc.

Today’s Trading

Previous close32.67
Today’s open33.01
Day’s range32.72 - 33.71
Volume450,440
Average volume (3 months)275,249
Market cap$1.3B
Dividend yield--
Data as of 09/02/2015

Growth & Valuation

Earnings growth (last year)+3.53%
Earnings growth (this year)+40.15%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+8.49%
P/E ratio34.9
Price/Sales3.68
Price/Book2.23

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc+1.43+3.87%
HRTXHeron Therapeutics I...+1.37+3.83%
ZSPHZS Pharma Inc+3.47+6.82%
NLNKNewLink Genetics Cor...+2.94+6.78%
Data as of 09/02/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)$0.50
Annual revenue (last year)$339.3M
Annual profit (last year)$36.7M
Net profit margin10.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
Executive VP-Corporate Services
Robert G. Kramer
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers